CB47782-22 - 0x000000000000690C
Healthy Males & Females
Mesmerize
* Stipend may pay up to reflected amount.
Start Date:
May 18, 2026 - 1:00pm
End Date:
June 16, 2026 - 8:00am
Study Details
Study Number: CB47782
Group Number: 22
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,750.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat schizophrenia.
Route of Administration: Oral
Blood Draws: 50
Study Schedule
Schedule Type: Long Term
Study Length: 17 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 5/7/2026 |
| Friday | 5/8/2026 |
| Monday | 5/11/2026 |
| Thursday | 5/14/2026 |
| Friday | 5/15/2026 |
| Monday | 5/18/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 5/7/2026 |
| Friday | 5/8/2026 |
| Monday | 5/11/2026 |
| Thursday | 5/14/2026 |
| Friday | 5/15/2026 |
| Monday | 5/18/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | 5/18/2026 1:00:00 PM | Thursday | 6/4/2026 8:00:00 AM | 1 | Lincoln |
| Return | Tuesday | 6/9/2026 6:30:00 AM | Tuesday | 6/9/2026 8:00:00 AM | 1 | Lincoln |
| Return | Tuesday | 6/16/2026 6:30:00 AM | Tuesday | 6/16/2026 8:00:00 AM | 1 | Lincoln |
